{"id":"W2557965693","doi":"10.1182/blood.v126.23.1596.1596","title":"Treatment Patterns and Healthcare Costs in Newly Diagnosed Patients with Chronic Myeloid Leukemia Receiving Dasatinib or Nilotinib As First-Line Therapy in the United States: A Retrospective Claims Database Analysis","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Nilotinib; Medicine; Dasatinib; Discontinuation; Internal medicine; Myeloid leukemia; Retrospective cohort study; Imatinib","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001173267,0.0002574683,0.0004991093,0.001715439,0.00033818,0.0009848502,0.0005554603,0.0004487714,0.0009731246],"category_scores_gemma":[0.004133038,0.0003637558,0.0008710336,0.003688046,0.0002001919,0.0006066788,0.0005622864,0.0006315816,0.0001504589],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007913332,"about_ca_system_score_gemma":0.0006446879,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01217542,"about_ca_topic_score_gemma":0.01147734,"domain_scores_codex":[0.9983053,0.0003883239,0.000497273,0.0003521028,0.0003292872,0.0001275935],"domain_scores_gemma":[0.9941618,0.0006964597,0.004265768,0.0002607759,0.0003618058,0.0002534007],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00009053331,0.00002918781,0.9988171,0.00002343167,0.0001467609,0.00003499175,0.00002723898,0.00006985412,0.00002984305,0.00002363167,0.0001929735,0.000514331],"study_design_scores_gemma":[0.00001900451,0.00006734439,0.9977549,0.00003128668,0.0001157178,0.0002877879,0.0001807765,0.001000172,0.00006574611,0.00003003999,0.0004400216,0.000007287288],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991816,0.0006635595,0.0001450646,0.0001049012,0.00000802959,0.00002902114,0.006838502,0.000004554675,0.0003904536],"genre_scores_gemma":[0.9954002,0.0002540813,0.0001306625,0.0000583378,0.00001250164,0.00003191372,0.004042612,0.000002041299,0.00006763264],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01217542,"threshold_uncertainty_score":0.02420908,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03002437962263441,"score_gpt":0.2961061800249184,"score_spread":0.266081800402284,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}